QUANTUM BIOPHARMA LTD (QNTM)
Institutional ownership reported to the SEC as of Q2 2026, across 8 quarters.
27
Reporting holders
$1.5M
Reported value
0.0%
Held as options
+4
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
Five percent filings
Anyone crossing 5% of a company must say so within days - far sooner than the next quarterly holdings report. A 13D declares an intent to influence the company; a 13G is the passive version. See all activist filings →
| Filed | Form | Filer | % of class |
|---|---|---|---|
| 2026-07-08 | 13G | AdvisorShares Trust | 5.3% |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 27 | $1.5M | 415,119 | 6 | 7 | 3 | 0.0% |
| Q1 2026 | 23 | $1.2M | 242,100 | 7 | 5 | 0 | 0.0% |
| Q4 2025 | 22 | $860.8K | 117,921 | 6 | 4 | 5 | 0.0% |
| Q3 2025 | 16 | $904.2K | 55,092 | 3 | 6 | 2 | 0.0% |
| Q2 2025 | 16 | $2.0M | 99,891 | 6 | 2 | 5 | 0.0% |
| Q1 2025 | 13 | $552.7K | 69,905 | 7 | 2 | 2 | 0.0% |
| Q4 2024 | 9 | $256.4K | 69,772 | 1 | 2 | 3 | 0.0% |
| Q3 2024 | 9 | $106.0K | 26,490 | 9 | 0 | 0 | 0.0% |